| Date Filed | Type | Description |
| 06/05/2023 |
4
| Mokari Atabak (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 1,651 shares
@ $22.97, valued at
$37.9k
Granted 1,651 shares
@ $0 |
|
| 09/06/2022 |
4
| Mokari Atabak (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 793 shares
@ $25.98, valued at
$20.6k
Granted 793 shares
@ $0 |
|
| 02/11/2022 |
4
| Mokari Atabak (CFO) has filed a Form 4 on CORCEPT THERAPEUTICS INC|
Txns:
| Granted 100,000 options to buy
@ $19.26, valued at
$1.9M
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/09/2020 |
4
| Mokari Atabak (CFO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 21,792 restricted stock units
@ $0 |
|
| 02/04/2020 |
4
| Mokari Atabak (CFO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 540,000 options to buy
@ $1.36, valued at
$734.4k
|
|
| 12/20/2018 |
4
| Mokari Atabak (Sr. VP and CFO) has filed a Form 4 on BELLICUM PHARMACEUTICALS, INC|
Txns:
| Granted 300,000 options to buy
@ $3.42, valued at
$1M
|
|
| 12/20/2018 |
3
| Mokari Atabak (Sr. VP and CFO) has filed a Form 3 on BELLICUM PHARMACEUTICALS, INC |
| 12/13/2018 |
4
| Mokari Atabak (CFO and VP Corp Development) has filed a Form 4 on IRIDEX CORP|
Txns:
| Paid exercise price by delivering 5,833 shares
@ $0
Paid exercise price by delivering 180 shares
@ $4.1, valued at
$738 |
|
| 07/31/2018 |
4
| Mokari Atabak (CFO and VP Corp Development) has filed a Form 4 on IRIDEX CORP|
Txns:
| Granted 16,800 shares
@ $0 |
|
| 07/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/13/2016 |
3
| Mokari Atabak (CFO and VP, Corp Development) has filed a Form 3 on IRIDEX CORP |